2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$0.85+$0.007 (+0.84%)
Price as of Aug 21, 2026 7:07 PM EDT- $25.7MMarket Cap
- 5.64%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$0.85+$0.007 (+0.84%)
LGVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.84 | ||
Change | +$0.02 (+2.02%) | ||
Open | $0.86 | ||
High | $0.87 | ||
Low | $0.82 | ||
Previous Close | $0.83 | ||
Volume | 770,448 | ||
30-Day Average Volume | 493,046 | ||
1-Week Change | 14.19% | ||
1-Month Change | 38.15% | ||
1-Year Change | 5.64% | ||
3-Year Change | -96.70% | ||
5-Year Change | -97.63% | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $15.5M | ||
Market Cap | $25.7M | ||
Enterprise Value | $15.6M | ||
Period: QTR TTM FY | |||
Revenue | $287,000.00 | ||
Net Income | -$6.1M | ||
Free Cash Flow | -$5.8M | ||
EBIT | -$6.1M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $7.0M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/27/2024 | ||
Earnings & Revenue